D
Forte Biosciences, Inc. FBRX
$18.31 -$0.78-4.09% NASDAQ
Recommendation
Prev Close
$19.09
Volume
65,093
Avg Vol (90D)
92,162
Market Cap
$340.40M
Dividend & Yield
--
52-Week Range
$4.90 - $28.68
P/E (TTM)
--
EPS (TTM)
-$4.49
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX)
11/28/2025 - MarketBeat
Forte Biosciences (NASDAQ:FBRX) Upgraded by Evercore ISI to Strong-Buy Rating
11/27/2025 - Ticker Report
Forte Biosciences, Inc. (NASDAQ:FBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages
11/26/2025 - MarketBeat
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Brokerages
11/25/2025 - Ticker Report
Forte Biosciences initiated with bullish view at Evercore ISI, here's why
11/25/2025 - The Fly
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
11/24/2025 - GuruFocus
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
11/24/2025 - Business Wire
Forte Biosciences (FBRX, $17.97) price may drop as it broke higher Bollinger Band on Nov 18, 2025
11/19/2025 - Tickeron - Stocks
Forte Biosciences (NASDAQ:FBRX) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS
11/16/2025 - MarketBeat
Forte Biosciences (NASDAQ:FBRX) Downgraded to Sell Rating by Wall Street Zen
11/16/2025 - MarketBeat
Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress
11/15/2025 - TipRanks Financial Blog
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
11/14/2025 - GuruFocus
FBRX: Forte Biosciences Advances FB102 with Key Clinical Trials
11/14/2025 - GuruFocus
Forte Biosciences reports Q3 EPS (99c), consensus ($1.07)
11/14/2025 - TipRanks Financial Blog
Forte Biosciences reports Q3 EPS (99c), consensus ($1.07)
11/14/2025 - The Fly
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
11/14/2025 - Business Wire
Forte Biosciences (FBRX, $13.84) Aroon Indicator entered a Downtrend on November 13, 2025.
11/14/2025 - Tickeron - Stocks
Forte Biosciences (FBRX, $14.46) Aroon Indicator entered a Downtrend on November 12, 2025.
11/13/2025 - Tickeron - Stocks
Forte Biosciences (FBRX, $14.46) entered Downtrend as Momentum indicator drops below 0 level on Nov 12, 2025
11/13/2025 - Tickeron - Stocks
Forte Biosciences (FBRX, $14.09) Aroon Indicator entered a Downtrend on November 11, 2025.
11/12/2025 - Tickeron - Stocks
Forte Biosciences (FBRX, $13.67) Aroon Indicator entered a Downtrend on November 10, 2025.
11/11/2025 - Tickeron - Stocks
Forte Biosciences (FBRX, $13.67) Stochastic Oscillator left the oversold zone on November 10, 2025
11/11/2025 - Tickeron - Stocks
We're Not Very Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate
11/11/2025 - Simply Wall St
Forte Biosciences (FBRX) to Release Quarterly Earnings on Thursday
11/6/2025 - MarketBeat
Forte Biosciences (FBRX, $10.91) Stochastic Oscillator left the oversold zone on November 04, 2025
11/5/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$53.38M
EBIT (TTM)
-$53.44M
Net Income (TTM)
-$51.74M
Balance Sheet
Total Assets (Q)
$97.09M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$12.99M
Book Value Per Share (Q)
$4.72
Cash Flow
Cash from Operations (TTM)
-$44.43M
Cash from Investing (TTM)
$247.00K
Cash from Financing (TTM)
$121.23M
Net Change in Cash (TTM)
$77.05M
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
2.02
7-Day Total Return
-0.57%
30-Day Total Return
56.76%
60-Day Total Return
65.55%
90-Day Total Return
57.44%
Year to Date Total Return
-27.54%
1-Year Total Return
-23.71%
2-Year Total Return
46.48%
3-Year Total Return
-26.27%
5-Year Total Return
-98.05%
52-week Low
Apr 23, 2025 - $4.90
52-week High
Dec 06, 2024 - $28.68
Valuation
Market Cap
$340.40M - Small Cap
Enterprise Value
$246.99M
Price/Sales (TTM)
--
Price/Book (Q)
4.05
Dividends and Shares
Shares Outstanding
17.79
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.fortebiorx.com
Phone Number
310 618 6994
Address
3060 Pegasus Park Drive
Dallas, TX 75247
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed